The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis
- 31 October 1999
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (10), 1688-1702
- https://doi.org/10.1016/s0149-2918(99)80048-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- COX-2 inhibitorsThe Lancet, 1999
- The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritisBiopharmaceutics & Drug Disposition, 1998
- Clinical Pharmacokinetics of DiclofenacClinical Pharmacokinetics, 1997
- Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsNature, 1996
- Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The rotterdam studyArthritis & Rheumatism, 1996
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- TOTAL AND FREE METHOTREXATE PHARMACOKINETICS, WITH AND WITHOUT PIROXICAM, IN RHEUMATOID ARTHRITIS PATIENTSRheumatology, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney FunctionThe Journal of Clinical Pharmacology, 1991
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976